$106.73
0.970.92%
At close: -
$107.41
0.680.64%
After Hours: Apr 25, 4:03 PM EDT
Comments
Loading...
Neurocrine Biosciences Earnings Estimates, EPS & Revenue | NASDAQ:NBIX | Benzinga
Neurocrine Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 5
EPS Estimate
$1.250
Quarterly Revenue Estimate
$587.06M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$2.36B
Analyze the earnings history of Neurocrine Biosciences using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NBIX | Neurocrine Biosciences | $1.20 | $1.25 | — | — | $515.30M | $587.06M | — | — | 05/05/2025 | Get Alert |
| NBIX | Neurocrine Biosciences | $1.54 | $1.71 | $1.69 | -1.17% | $515.20M | $628.96M | $627.70M | -0.20% | 02/06/2025 | Get Alert |
| NBIX | Neurocrine Biosciences | $1.54 | $1.51 | $1.81 | 19.87% | $498.80M | $600.63M | $622.10M | — | 10/30/2024 | Get Alert |
| NBIX | Neurocrine Biosciences | $1.25 | $1.03 | $1.63 | 58.25% | $452.70M | $547.07M | $590.20M | 7.88% | 08/01/2024 | Get Alert |
| NBIX | Neurocrine Biosciences | -$0.51 | $1.01 | $1.20 | 18.81% | $420.40M | $511.97M | $515.30M | 0.65% | 05/01/2024 | Get Alert |
| NBIX | Neurocrine Biosciences | $1.24 | $1.15 | $1.54 | 33.91% | $412.00M | $518.13M | $515.20M | -0.57% | 02/07/2024 | Get Alert |
| NBIX | Neurocrine Biosciences | $1.08 | $0.98 | $1.54 | 57.14% | $387.90M | $469.92M | $498.80M | 6.15% | 10/31/2023 | Get Alert |
| NBIX | Neurocrine Biosciences | $0.84 | $0.77 | $1.25 | 62.34% | $378.20M | $448.89M | $452.70M | 0.85% | 08/01/2023 | Get Alert |
| NBIX | Neurocrine Biosciences | $0.30 | $0.13 | -$0.51 | -492.31% | $310.60M | $409.35M | $420.40M | 2.70% | 05/03/2023 | Get Alert |
| NBIX | Neurocrine Biosciences | $0.04 | $1.14 | $1.24 | 8.77% | $312.00M | $409.09M | $412.00M | 0.71% | 02/06/2023 | Get Alert |
| NBIX | Neurocrine Biosciences | $0.64 | $0.80 | $1.08 | 35.00% | $296.00M | $376.50M | $387.90M | 3.03% | 11/01/2022 | Get Alert |
| NBIX | Neurocrine Biosciences | $0.63 | $0.59 | $0.84 | 42.37% | $288.90M | $341.31M | $378.20M | 10.81% | 08/04/2022 | Get Alert |
| NBIX | Neurocrine Biosciences | $0.49 | $0.34 | $0.30 | -11.76% | $236.60M | $303.40M | $310.60M | 2.37% | 05/04/2022 | Get Alert |
| NBIX | Neurocrine Biosciences | $0.91 | $0.52 | $0.04 | -92.31% | $247.90M | $316.79M | $312.00M | -1.51% | 02/11/2022 | Get Alert |
| NBIX | Neurocrine Biosciences | $0.97 | $0.60 | $0.64 | 6.67% | $258.50M | $297.65M | $296.00M | -0.55% | 11/01/2021 | Get Alert |
| NBIX | Neurocrine Biosciences | $1.42 | $0.49 | $0.63 | 28.57% | $302.40M | $274.38M | $288.90M | 5.29% | 08/03/2021 | Get Alert |
| NBIX | Neurocrine Biosciences | $0.82 | $0.51 | $0.49 | -3.92% | $237.10M | $250.63M | $236.60M | -5.60% | 05/05/2021 | Get Alert |
| NBIX | Neurocrine Biosciences | $1.05 | $0.54 | $0.91 | 68.52% | $244.10M | $262.40M | $247.90M | -5.53% | 02/04/2021 | Get Alert |
| NBIX | Neurocrine Biosciences | $0.90 | $0.22 | $0.97 | 340.91% | $222.09M | $283.04M | $258.50M | -8.67% | 11/09/2020 | Get Alert |
| NBIX | Neurocrine Biosciences | $0.71 | $0.73 | $1.42 | 94.52% | $183.58M | $260.34M | $302.40M | 16.16% | 08/03/2020 | Get Alert |
| NBIX | Neurocrine Biosciences | -$1.12 | $0.54 | $0.82 | 51.85% | $138.40M | $223.87M | $237.10M | 5.91% | 05/06/2020 | Get Alert |
Neurocrine Biosciences (NBIX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-06 | $1.69 | $1.71 | -1.17 % |
| Q3 | 2024-10-30 | $1.81 | $1.51 | 19.9 % |
| Q2 | 2024-08-01 | $1.63 | $1.03 | 58.3 % |
| Q1 | 2024-05-01 | $1.20 | $1.01 | 18.8 % |
Neurocrine Biosciences (NBIX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-06 | $627.70M | $628.96M | -0.20 % |
| Q2 | 2024-08-01 | $590.20M | $547.07M | 7.88 % |
| Q1 | 2024-05-01 | $515.30M | $511.97M | 0.65 % |
| Q4 | 2024-02-07 | $515.20M | $518.13M | -0.57 % |
FAQ
When is Neurocrine Biosciences (NASDAQ:NBIX) reporting earnings?
Neurocrine Biosciences (NBIX) is scheduled to report earnings on May 5, 2025. The last reported earnings were for reported on February 6, 2025 for Q4.
What were the latest earnings per share (EPS) for Neurocrine Biosciences (NASDAQ:NBIX)?
The Actual EPS was $1.69, which missed the estimate of $1.71.
What were Neurocrine Biosciences’s (NASDAQ:NBIX) revenues?
The Actual Revenue was $627.7M, which missed the estimate of $629M.
Browse earnings estimates, EPS, and revenue on all stocks.
